TheProfitWatch

CADL - Candel Therapeutics, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
4.46 0.09 (2.13%) 0.0 (0.0%) 0.0 (0.0%) -0.02 (-0.44%) 0.0 (0.0%) 0.11 (2.59%) 0.06 (1.35%) 0.02 (0.45%)

Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.09
Diluted EPS:
-0.09
Basic P/E:
-50.6111
Diluted P/E:
-50.6111
RSI(14) 1m:
58.33
VWAP:
4.55
RVol:

Events

Period Kind Movement Occurred At

Related News